ACR Lung Cancer Screening Podcast

The ACR Lung Cancer Screening Steering Committee has partnered with the National Lung Cancer Roundtable to create a new podcast titled Pleural Space | Conversations in Lung Cancer, featuring candid and casual conversations about the work being done in lung cancer and health equity with the people doing that work.

The new season, “The Power of Partnerships,” is listed below and highlights collaborations between patients, primary care, pulmonology, radiology, and health equity experts sharing new data and existing programs aimed at increasing lung cancer screening rates in the underserved population.

The first season, “Mythbusting Lung Cancer Screening,” launched in 2020 and focused on combatting common myths found in treatment and discussion of lung cancer.

Lung Cancer 201: Expanding Horizons

The Power of Data - New Episode Coming Soon

Season 2: Power of Partnerships

Season 2 Episodes

Thoracic Surgery and the Modern Paradigm for Screening Nodule Management

To wrap up our “Power of Partnerships” series, Douglas Wood, MD, FACS, FRCSEd has a conversation about the thoracic surgeon’s role in lung cancer screening with his surgical colleagues, Leah Backhus, MD, MPH, FACS; Tom Varghese, MD, MS; and Farhood Farjah, MD, MPH, FACS. They discuss the surgeon’s role in screening programs, evaluating nodules from a surgical perspective, and how to avoid harm and minimize unnecessary surgery for patients without cancer.

 

Reaching Vulnerable Populations

Continuing the focus on patients, Efrén J. Flores, MD, speaks with Chi-Fu Jeffrey Yang, MD, Alexandra L. Potter, and Angela Zhou from the American Lung Cancer Screening Initiative (ALSCI) about outreach to populations vulnerable to lung cancer that are underserved in lung screening. This includes identifying how stigma is a barrier, finding ways to establish education and trust in communities typically distrustful of the medical establishment, and interdisciplinary approaches to cancer screening.

 

Patients Are Looking for a Community: How Lung Cancer Advocacy Works

For 2022's National Patient Recognition Week, Elridge Proctor, MPA, of the Go2 Foundation sits down with Heidi Onda, MHE, and Pierre Onda, MD, MPH, of the White Ribbon Project and Nichelle Stigger from LUNGevity to discuss how they went from patient to patient advocates and ways those without lung cancer can use their voices for change.

 

Patient and Family Centered Care in Lung Cancer

Debra Dyer, MD, FACR, and experienced patient advocates Rhonda Meckstroth and Gina Hollenbeck, BSN, talk about shifting lung cancer from a more quantitative perspective to a patient and family centered one, including changing the face of lung cancer and how medicine can further support patients beginning immediately post diagnosis.

 

Lung Cancer Screening and the Veteran Experience: Past, Present and Future

Nichole Tanner, MD, MCSR, nurse practitioner Shannon Magee, FNP, and experienced patient advocate Jim Pantelas discuss the unique challenges of treating lung cancer through the Veterans Administration hospital system, and the support provided to veterans pre- and post-diagnosis.

 

Social Determinants of Health and Lung Cancer Care and Control

Ruth Carlos, MD, MS, FACR, Lucy Spalluto, MD, MPH, and patient advocate Andrea Borondy-Kitts, discuss social determinants of health and how they affect lung cancer diagnosis and treatment, including what disparities currently exist, how policy changes could reduce those disparities and how you can help.

 

Stigma and Nihilism in Lung Cancer Care and Control (Part 1)

Jamie L. Studts PhD, FSBM, and experienced patient advocates Jill Feldman and Jim Pantelas discuss stigma surrounding lung cancer from internal and external sources and the work being done to combat stigma.

 

Stigma and Nihilism in Lung Cancer Care and Control (Part 2)

Jamie L. Studts, PhD, FSBM, continues the conversation about stigma and nihilism from a clinician scientist perspective with Jamie S. Ostroff, PhD, and Lisa Carter-Harris, MD, PhD, APRN, ANP-C, FAAN, including how language contributes to stigma and the new International Association for the Study of Lung Cancer (IASLC) language guide.